U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07883798) titled 'Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic Lesions' on Oct. 13.
Brief Summary: OLIGYNE-10 RT is an international registry of adults with gynecologic cancer and a limited number of active sites of cancer spread who receive radiotherapy to at least one metastatic lesion during routine care. The registry combines information from existing medical records with information collected prospectively. Treating clinical teams choose radiotherapy, imaging, systemic treatment, and follow-up. The registry does not assign treatment or require additional imaging or visits.
The classical cohort includes people with 1 to 5 ...